30% of GLP-1 patients quit in the first month, and every one of them opens a ticket before they go.
GLP-1 and peptide telehealth support tickets are the patient requests that follow an injectable prescription home: delivery and cold-chain problems, refill timing, subscription changes, refunds, payment failures, side-effect reports and questions triggered by FDA rule changes. In 2026 these tickets cluster around 7 types, and most of them are administrative actions that AI agents can complete end-to-end.
Blue Health Intelligence found 30% of GLP-1 patients stop in month 1 and 58% within 12 weeks, each exit producing a cancellation or refund ticket.
Prime Therapeutics reports 1-year persistence nearly doubled from 33.2% in 2021 to 60.9% in 2024, so the surviving cohort now generates years of refill tickets.
The FDA changed the status of 12 compounded peptides on a single day in April 2026, producing a same-day wave of "can I still get this?" tickets.
Healthcare tickets cost $30 or more each per LiveChatAI, and 5 of the 7 common ticket types need no clinical judgement.
Last updated: September 2026
GLP-1 and peptide telehealth is a subscription business wrapped around a cold-chain pharmacy wrapped around a regulated prescription. Each layer generates its own ticket type, and the layers interact: a warm delivery becomes a refund request, a refund request becomes a cancellation, and a cancellation becomes a churn statistic. Meanwhile the regulatory layer resets the whole queue whenever the FDA moves a substance on or off a list.
Support teams that treat this as one undifferentiated inbox burn out. Teams that classify the 7 ticket types, automate the administrative ones and route the clinical ones cleanly get faster resolutions, fewer chargebacks and clinicians who only see what needs them.
What Are the Most Common GLP-1 and Peptide Telehealth Support Tickets?
The most common GLP-1 and peptide telehealth support tickets are delivery and cold-chain claims, refill and reorder timing, subscription pause or cancellation, refunds and billing disputes, payment failures, side-effect intake, and regulatory-change questions. Delivery, billing and subscription tickets typically dominate volume; side-effect and dosing tickets are fewer but carry clinical risk.
The billing share is unusually high for healthcare. Better Business Bureau complaint files for multiple peptide sellers show repeating patterns: recurring charges the patient did not expect, cancellations buried in marketing emails, and refunds refused on unopened product. Persistence data explains the volume. Blue Health Intelligence, analysing nearly 170,000 commercial members, found 30% stop within the first month and 58% within 12 weeks, and each exit is a conversation with support.
Titration schedule: the clinician-set plan for increasing an injectable dose over weeks, which determines when each refill must ship.
Cold-chain excursion: any period during shipping when a temperature-sensitive medication leaves its required range, for semaglutide 2°C to 8°C.
Lorikeet is an AI customer support platform that resolves tickets end-to-end, processing refunds, updating subscriptions and completing multi-step workflows across chat, email and voice. For GLP-1 and peptide telehealth companies, Lorikeet resolves the administrative ticket types in this article inside existing pharmacy and billing systems and routes side-effect and dosing questions to licensed clinicians with full context.
Why Do GLP-1 and Peptide Support Volumes Spike?
GLP-1 and peptide support volumes spike for 3 reasons: early-treatment attrition concentrates cancellations in the first 12 weeks, regulatory events change what can be shipped on a fixed date, and the physical cold chain fails in heat waves and holiday shipping. None of these spikes align with a staffing calendar.
Attrition is front-loaded
Blue Health Intelligence's 30% first-month discontinuation rate means a clinic onboarding 1,000 patients a month should expect roughly 300 cancellation or pause conversations from that cohort within 30 days. Prime Therapeutics data shows 1-year persistence rising from 33.2% in 2021 to 60.9% in the first half of 2024, so the patients who stay now generate refill tickets for far longer.
Regulatory dates move the whole queue
The FDA declared the semaglutide shortage resolved on February 21, 2025, ending compounding discretion on April 22 and May 22, 2025. On April 23, 2026, 12 peptides left the Category 2 list per Orrick, with 7 more reviewed on July 23 and 24, 2026. Every date is a same-day ticket surge.
The cold chain breaks at the doorstep
The FDA has flagged compounded GLP-1s arriving warm with degraded ice packs. Compounded vials carry no temperature indicator, so the patient reports the problem and support decides what happens next. Fortune's July 2026 reporting sizes the addressable peptide market at roughly $30 billion and ties its growth to exactly this kind of compliance and fulfilment discipline.
Which 7 GLP-1 and Peptide Support Tickets Should You Automate First?
The 7 GLP-1 and peptide support tickets to automate first are delivery claims, refill timing, subscription changes, refunds, payment failures, regulatory notices and side-effect intake. The first 6 can be resolved end-to-end by an AI agent; the 7th is automated intake and routing, never automated advice.
Warm, late or missing delivery. Verify carrier scans and excursion window, instruct the patient not to use the vial, file the pharmacy replacement and confirm the new date. One contact instead of the 3 that manual back-and-forth usually takes.
Refill and reorder timing. Read the active prescription, last ship date and titration schedule; confirm or move the next shipment. This is logistics from the clinician's plan, not a dosing decision.
Subscription pause, skip or cancel. Apply the published policy, process the change, send written confirmation. Given 30% first-month attrition, this is the highest-volume ticket in the queue and the one BBB complaints most often cite.
Refunds and billing disputes. Check eligibility against policy and order history, issue the refund or credit, and document it. Our guide to AI for refund status covers the pattern.
Payment failures. Retry, update card details, prevent the involuntary cancellation. See automating failed payment recovery for the workflow.
Regulatory-change notices. Explain a status change in clinician-approved language, confirm what the patient can still receive, and book a provider consult if a new prescription is needed. Never imply a compounded product is the same as an approved one; the FDA warned 30 telehealth companies for exactly that.
Side-effect intake and escalation. Collect structured symptoms, detect red-line terms, and route to a licensed clinician with the transcript. Under California AB 3030 the agent must disclose AI use once clinical content appears.
What Results Do Telehealth Teams See From Ticket Automation?
Telehealth teams that automate the administrative ticket types see resolution rates comparable to the wider AI support market, lower cost per ticket and faster handling of the time-sensitive tickets that otherwise become refunds and chargebacks. The gains depend on resolving actions in systems, not deflecting patients to help articles.
According to Intercom, its Fin agent averages a 76% resolution rate across 12,000 customers, and Ada reports around 52% automated resolution across more than 550 deployments. LiveChatAI's 2025 benchmarks put phone contacts at $17 to $25, chat at $10 to $16 and self-service at $1 to $4, with healthcare rarely under $30 per ticket. Gartner predicts agentic AI will autonomously resolve 80% of common service issues by 2029.
For a telehealth company handling 8,000 tickets a month with 6 of 7 ticket types administrative, automating even 60% removes about 4,800 tickets from the human queue. At the $30 healthcare benchmark that is roughly $144,000 a month, before counting fewer chargebacks and faster replacements. Our cost per ticket benchmarks show how to calculate your own baseline.
6 of the 7 most common GLP-1 tickets are administrative, and each costs $30 or more to handle by hand. See how Lorikeet resolves telehealth tickets end-to-end.
How Should You Route Clinical Versus Administrative Tickets?
Route GLP-1 and peptide tickets by asking one question: does the resolution require judgement about this patient's body, or an action in a system? System actions (refunds, ship dates, pauses, retries) go to the AI agent for full resolution. Body judgements (dose, missed dose, side effects, interactions) go to a licensed clinician with the transcript attached.
The hard cases are the tickets that start administrative and turn clinical. "Where is my refill?" becomes clinical when the patient mentions they have been off the medication for 3 weeks and wants to restart at the old dose. The agent needs guardrails that detect that shift mid-conversation, stop resolving, disclose AI use where state law requires it, and hand off with context rather than a "please contact your provider" dead end.
Then review every conversation, not a sample. Lorikeet Coach reviews 100% of AI conversations against clinical and policy rules, and our guide to AI for churn prevention covers the proactive side: reaching the first-month cohort before they open the cancellation ticket.
Lorikeet's Take on GLP-1 and Peptide Support Tickets
At Lorikeet, we've seen telehealth teams staff for average volume and drown on FDA dates, then buy a chatbot that deflects the refund and answers the dosing question. Most vendors will tell you to grow the knowledge base. The reality is that GLP-1 and peptide patients open tickets to get something done: a replacement vial shipped, a subscription paused, a prescription moved to a new pharmacy. Lorikeet is built to complete those actions inside your pharmacy and billing systems, to stop at the clinical line, and to review every conversation afterwards. If your queue looks like the 7 types above, see how Lorikeet's Resolution Loop resolves them.
Key Takeaways
30% of GLP-1 patients stop in month 1 and 58% within 12 weeks per Blue Health Intelligence; plan support capacity around that curve.
6 of the 7 most common ticket types are administrative and automatable end-to-end; only side-effect intake requires clinician routing.
Regulatory dates such as April 23, 2026 (12 peptides delisted) create same-day surges that headcount cannot absorb.
Healthcare tickets cost $30 or more per LiveChatAI; automating 60% of an 8,000-ticket queue saves roughly $144,000 a month.
Route by judgement versus action, detect the switch mid-conversation, and QA 100% of AI conversations rather than a sample.
GLP-1 and peptide telehealth support is not one problem but 7, and 6 of them are logistics wearing a healthcare costume. The persistence curve tells you when the cancellations arrive, the FDA calendar tells you when the regulatory questions arrive, and the weather tells you when the vials arrive warm. Each is predictable, and each is mostly automatable.
Teams that classify the queue this way will handle the category's growth without support costs growing with it, and their clinicians will see only the tickets that genuinely need a licence.
If your inbox looks like this list, talk to Lorikeet about resolving the 6 administrative ticket types end-to-end and routing the 7th to the right clinician every time.
